Viveve Medical, Inc.
VIVE
$0.0002
$0.000.00%
| 09/30/2022 | 06/30/2022 | ||||
|---|---|---|---|---|---|
| Revenue | -6.18% | 9.38% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -6.18% | 9.38% | |||
| Cost of Revenue | -24.18% | 13.63% | |||
| Gross Profit | 85.71% | -8.13% | |||
| SG&A Expenses | 0.44% | -7.12% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.88% | -4.20% | |||
| Operating Income | 7.13% | 8.28% | |||
| Income Before Tax | 14.19% | 1.48% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 14.19% | 1.48% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 14.19% | 1.48% | |||
| EBIT | 7.13% | 8.28% | |||
| EBITDA | 7.16% | 8.29% | |||
| EPS Basic | 11.19% | 0.86% | |||
| Normalized Basic EPS | 7.10% | 9.38% | |||
| EPS Diluted | 11.19% | 0.86% | |||
| Normalized Diluted EPS | 7.10% | 9.38% | |||
| Average Basic Shares Outstanding | 0.23% | 0.19% | |||
| Average Diluted Shares Outstanding | 0.23% | 0.19% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||
